Corvus Pharmaceuticals, Inc.CRVSNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-81.24%
↓ 90% below average
Average (9y)
-42.73%
Historical baseline
Range
High:86.58%
Low:-415.00%
CAGR
+5.7%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -81.24% |
| 2023 | 36.76% |
| 2022 | 13.59% |
| 2021 | -415.00% |
| 2020 | 86.58% |
| 2019 | 12.87% |
| 2018 | 37.13% |
| 2017 | -15.25% |
| 2016 | -53.25% |
| 2015 | -49.51% |